Search Results - "Swedin, A."

THE REVII TRIAL: LENALIDOMIDE AND DEXAMETHASONE AS SECOND LINE TREATMENT IN MYELOMA FOLLOWED BY EXTENDED LENALIDOMID VS LEN/DEX by Lund, J., Gruber, A., Lauri, B., Blimark, C., Swedin, A., Hansson, M., Forsberg, Karin, Ahlberg, L., Carlsson, C., Waage, A., Gimsing, P., Vangsted, A. J., Frolund, U., Hardling, M., Mellqvist, U. H., Nahi, H.

Get full text

Improved survival in myeloma patients: starting to close in on the gap between elderly patients and a matched normal population by Liwing, Johan, Uttervall, Katarina, Lund, Johan, Aldrin, Anders, Blimark, Cecilie, Carlson, Kristina, Enestig, Jon, Flogegård, Max, Forsberg, Karin, Gruber, Astrid, Haglöf Kviele, Helene, Johansson, Peter, Lauri, Birgitta, Mellqvist, Ulf‐Henrik, Swedin, Agneta, Svensson, Magnus, Näsman, Per, Alici, Evren, Gahrton, Gösta, Aschan, Johan, Nahi, Hareth

“…Summary The outcome for multiple myeloma patients has improved since the introduction of bortezomib, thalidomide and lenalidomide. However, studies comparing…”
Get full text

Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial by Jakobsen Falk, Ingrid, Lund, Johan, Gréen, Henrik, Gruber, Astrid, Alici, Evren, Lauri, Birgitta, Blimark, Cecilie, Mellqvist, Ulf-Henrik, Swedin, Agneta, Forsberg, Karin, Carlsson, Conny, Hardling, Mats, Ahlberg, Lucia, Lotfi, Kourosh, Nahi, Hareth

“…Purpose Despite therapeutic advances, patients with multiple myeloma (MM) continue to experience disease relapse and treatment resistance. The gene ABCB1…”
Get full text

Linear reduction of clonal cells in stem cell enriched grafts in transplanted multiple myeloma by THUNBERG, U., BÅNGHAGEN, M., BENGTSSON, M., CHRISTENSEN, L. D., GEISLER, C. H., GIMSING, P., LENHOFF, S., MORTENSEN, B. T., OLOFSSON, T., SIMONSSON, B., SMEDEGAARD ANDERSEN, N., SUNDSTRÖM, C., SWEDIN, A., SÄLLSTRÖM, J. F., THURESSON, B., WESTIN, J., CARLSON, K.

“…In 30 patients with multiple myeloma who were scheduled for peripheral blood stem‐cell transplantation, a quantitative analysis of the stem cells following…”
Get full text

Aggressive course of primary plasma cell leukemia with unusual morphological and cytogenetic features by RICHTER, J, SWEDIN, A, OLOFSSON, T, JOHANSSON, B, AKERMAN, M, WINQVIST, I

“…A case of aggressive plasma cell leukemia with unusual morphological and cytogenetic features is reported. A 65-year-old man was admitted to hospital due to…”
Get full text

The Rev II Trial: Lenalidomide and Dexamethasone As Second Line Treatment in Myeloma Followed By Extended Lenalidomid Vs Len/Dex by Lund, Johan, Karstorp, Sigrid, Alici, Evren, Gruber, Astrid, Lauri, Birgitta, Blimark, Cecilie, Swedin, Agneta, Hansson, Markus, Forsberg, Karin, Ahlberg, Lucia, Conny, Carlsson, Waage, Anders, Gimsing, Peter, Vangsted, Annette Juul, Frølund, Ulf Christian, Hardling, Mats, Mellqvist, Ulf-Henrik, Nahi, Hareth

“…Background The indication for use of lenalidomide in second line of therapy has been based upon two phase III studies comparing lenalidomide and dexamethasone…”
Get full text

Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study by Hjorth, Martin, Hjertner, Øyvind, Knudsen, Lene Meldgaard, Gulbrandsen, Nina, Holmberg, Erik, Pedersen, Per Trøllund, Andersen, Niels Frost, Andréasson, Björn, Billström, Rolf, Carlson, Kristina, Carlsson, Margaretha S., Flogegård, Max, Forsberg, Karin, Gimsing, Peter, Karlsson, Torbjörn, Linder, Olle, Nahi, Hareth, Othzén, Annika, Swedin, Agneta

“…Objectives:  Thalidomide and bortezomib have been frequently used for second‐line therapy in patients with myeloma relapsing after or refractory to initial…”
Get full text

Lenalidomide versus lenalidomide plus dexamethasone prolonged treatment after second-line lenalidomide plus dexamethasone induction in multiple myeloma by Lund, Johan, Gruber, Astrid, Lauri, Birgitta, Duru, Adil Doganay, Blimark, Cecilie, Swedin, Agneta, Hansson, Markus, Forsberg, Karin, Ahlberg, Lucia, Carlsson, Conny, Waage, Anders, Gimsing, Peter, Vangsted, Annette Juul, Frolund, Ulf, Holmberg, Erik, Gahrton, Gösta, Alici, Evren, Hardling, Mats, Mellqvist, Ulf-Henrik, Nahi, Hareth

“…Lenalidomide (Len) plus dexamethasone (Dex) is approved for the treatment of relapsed or refractory multiple myeloma (RRMM). It is possible that single-agent…”
Get full text

Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second‐line lenalidomide + dexamethasone induction in multiple myeloma by Lund, Johan, Gruber, Astrid, Lauri, Birgitta, Duru, Adil Doganay, Blimark, Cecilie, Swedin, Agneta, Hansson, Markus, Forsberg, Karin, Ahlberg, Lucia, Carlsson, Conny, Waage, Anders, Gimsing, Peter, Vangsted, Annette Juul, Frølund, Ulf, Holmberg, Erik, Gahrton, Gösta, Alici, Evren, Hardling, Mats, Mellqvist, Ulf‐Henrik, Nahi, Hareth

“…Lenalidomide (Len) plus dexamethasone (Dex) is approved for the treatment of relapsed or refractory multiple myeloma (RRMM). It is possible that single‐agent…”
Get full text

The impact of ABCB1 single nucleotide polymorphisms on the outcome in lenalidomide treated multiple myeloma patients by Falk, IJ, Lund, J, Green, H, Gruber, A, Alici, E, Lauri, B, Blimark, C, Mellqvist, UH, Swedin, A, Forsberg, K, Carlsson, C, Hardling, M, Ahlberg, L, Nahi, H, Lotfi, K

Get full text

Is Multiple Myeloma a Chronic Disease? A Population Based Study Comparing 1843 Patients to a Matched Swedish Population by Nahi, Hareth, Liwing, Johan, Aldrin, Anders, Andreasson, Johan, Blimark, Cecilie, Carlson, Kristina, Enestig, Jon, Flogegård, Max, Forsberg, Karin, Gruber, Astrid, Johansson, Peter, Kviele, Helene, Lauri, Birgitta, Mellqvist, Ulf-Henrik, Näsman, Per, Swedin, Agneta, Svensson, Magnus, Uttervall, Katarina, Aschan, Johan

“…Abstract 2970 Evaluating real life outcomes in Multiple Myeloma (MM) pts in order to understand treatment outcome in clinical practice is very important. The…”
Get full text

Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: The first fusion gene involving BCR but not ABL by Fioretos, Thoas, Panagopoulos, Ioannis, Lassen, Carin, Swedin, Agneta, Billström, Rolf, Isaksson, Margareth, Strömbeck, Bodil, Olofsson, Tor, Mitelman, Felix, Johansson, Bertil

“…Constitutive activation of tyrosine kinases as a consequence of chromosomal translocations, forming fusion genes, plays an important role in the development of…”
Get full text

Clinical utility of immunoglobulin heavy chain gene rearrangement identification for tumour cell detection in multiple myeloma by Swedin, Agneta, Lenhoff, Stig, Olofsson, Tor, Thuresson, Britt, Westin, Jan

“…In an attempt to define the clinical utility of immunoglobulin heavy chain (IgH) gene rearrangement identification for tumour cell detection in multiple…”
Get full text

Fusion of the BCR and the Fibroblast Growth Factor Receptor-I (FGFRI) Genes as a Result of t(8; 22)(p11; q11) in a Myeloproliferative Disorder: The First Fusion Gene Involving BCR But Not ABL by Fioretos, T, Panagopoulos, I, Lassen, C, Swedin, A, Billstroem, R, Isaksson, M, Stroembeck, B, Olofsson, T, Mitelman, F, Johansson, B

“…Constitutive activation of tyrosine kinases as a consequence of chromosomal translocations, forming fusion genes, plays an important role in the development of…”
Get full text

CSF 5-HIAA and atmospheric pressure by Nordin, C, Swedin, A, Zachau, A

Get more information

Gradients of CSF monoamine metabolites: A comparison between male and female volunteers by Nordin, Conny, Eklundh, Thomas, Fernström, Vanja, Swedin, Agneta, Zachau, Anne C.

“…Lumbar puncture at the L4–5 level was performed on 12 healthy male and 12 healthy female volunteers. Confirming previous results, we found pronounced gradients…”
Get full text

Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder by Fioretos, Thoas, Panagopoulos, Ioannis, Lassen, C., Swedin, A., Billstrom, R., Isaksson, M., Strombeck, B., Olofsson, Tor, Mitelman, F., Johansson, B.

Get full text